News
Research from the School of Life Sciences hopes to accelerate the drug discovery process by providing key data that will aid in the design of new treatments to combat antimicrobial resistance (AMR).
News
Research from the School of Life Sciences hopes to accelerate the drug discovery process by providing key data that will aid in the design of new treatments to combat antimicrobial resistance (AMR).
Press release
World-leading expertise from the University of Dundee’s Centre for Targeted Protein Degradation (CeTPD) will contribute to a new, global effort to tackle some of the most significant challenges posed by cancer.
News
A one day symposium for the Scottish cryo-EM community took place on 30 November 2023
News
Professor Paul Birch and collaborators at the James Hutton Institute have been awarded ~£679k to study how the potato blight pathogen suppresses the potato immune system.
News
A collaboration between the research laboratories of Dr Mattie Pawlowic and Dr Susan Wyllie in the Wellcome Centre for Anti-Infectives Research at School of Life Sciences has generated a new tool that can be used for studying Cryptosporidium.
Press release
It may be known as the basis of whisky but scientists at two of Scotland’s leading scientific institutions have been tasked with distilling a new future for barley.
News
CeTPD Outreach is a public engagement sub-team branching in the new Centre for Targeted Protein Degradation as part of the University’s School of Life Sciences.
News
Review of the Year 20212 took place last week with the Dean, Julian Blow sharing the highlights of activity within the School from 2022.
News
Potato is the third most important food crop in the world and consumed by over a billion people. Pathogens can destroy entire crops and thereby threaten food security.
Press release
A successful collaboration between the University of Dundee and pharmaceutical company Eisai Co Ltd aiming to create innovative new cancer drugs has been extended for a further three years.
Press release
An international collaboration, featuring scientists from the University of Dundee, has made a breakthrough they hope will help futureproof a revolutionary new field of drug discovery by preventing resistance in cancer therapy.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Feature
Early career researchers in the School have received support from the Scottish Universities Life Sciences Alliance (SULSA) to establish new life sciences networks by providing funds towards the running of a network event.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
Press release
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in a field of chemical biology that is revolutionising drug discovery.
News
An industry-wide consortium, led by producer organisation G’s Growers and supported by the James Hutton Institute, the University of Dundee and James Hutton Limited, has won a UKRI-BBSRC collaborative training partnership award.
News
Plant Scientists at the University of Dundee and the James Hutton Institute (JHI) have won funding to establish a partnership with world-class researchers in Australia.
Press release
Work to build on Dundee’s world-class expertise in biomedical sciences is set to begin in earnest after the ‘Growing the Tay Cities Biomedical Cluster’ project was officially signed off by the Tay Cities Region Joint Committee today (February 19).
News
Senga Robertson-Albertyn received the prestigious RSE Innovators Prize for Public Engagement last week at the Royal Society of Edinburgh’s Winter Lecture at Wallace High School in Stirling.
News
Stephen Fry has lavished praise on University of Dundee staff and students who have won awards, named after the University’s former rector, for their success in sharing their work with the public.